Antabio's Seed - II Round

Antabio raised a round of funding on October 01, 2012. Investors include WiSEED.

Antabio is a biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.…

Articles about Antabio's Seed - II Round: